Interleukin-9-induced expression of M-Ras/R-Ras3 oncogene in T-helper clones

Blood

Volumn 94, Issue 5, 1999, Pages 1701-1710

  Louahed, Jamila ^b   Grasso, Luigi ^b   De Smet, Charles ^b   Van Roost, Emiel ^b   Wildmann, Claude ^b   Nicolaides, Nicholas C ^b   Levitt, Roy C ^b   Renauld, Jean Christophe ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 9; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE ISOLATION; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MOUSE; MULTIGENE FAMILY; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033199071     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1701.417k29_1701_1710     Document Type: Article

References (33)

1. Uyttenhove C, Simpson R, Van Snick J: Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc Natl Acad Sci USA 85:6934, 1988
2. Renauld J-C, Kermouni A, Vink A, Louahed J, Van Snick J: Interleukin 9 and its receptor: Involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol 57:353, 1995
3. Demoulin J-B, Renauld J-C: Interleukin 9 and its receptor: An overview of structure and function. Int Rev Immunol 16:345, 1998
4. Renauld J-C, van der Lugt N, Vink A, van Roon M, Godfraind C, Warnier G, Merz H, Feller A, Berns A, Van Snick J: Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 9:1327, 1994
5. Merz H, Houssiau FA, Orscheschek K, Renauld J-C, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink HK, Van Snick J, Feller AC: IL-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311, 1991
6. Nicolaides N, Holroyd KJ, Ewart SL, Eleff SM, Riser MB, Dragwa CR, Sullivan CD, Grasso L, Zhang LY, Messier CJ, Zhou T, Kleeberger SR, Buetow KH, Levitt RC: Interleukin 9: A candidate gene for asthma. Proc Natl Acad Sci USA 94:13175, 1997
7. McLane MP, Haczku AH, van de Rijn M, Weiss C, Ferrante V, MacDonald D, Renauld JC, Nicolaides NC, Levitt RC: Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Resp Cell Mol 19:713, 1998
8. Temann UA, Geba GP, Rankin JA, Flavell RA: Expression of Interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 188:1307, 1998
9. Holroyd KJ, Martinati LC, Trabetti E, Scherpbier T, Eleff SM, Boner AL, Pignatti PF, Kiser MB, Dragwa CR, Hubbard F, Sullivan CD, Grasso L, Messler CJ, Huang M, Hu Y, Nicolaides NC, Buetow KH, Levitt RC: Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics 52:233, 1998
10. Petit-Frère C, Dugas B, Braquet P, Mencia-Huerta J-M: Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 79:146, 1993
11. Dugas B, Renauld J-C, Pène J, Bonnefoy JY, Petit-Frère C, Braquet P, Bousquet J, Van Snick J, Mencia-Huerta J-M: Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 23:1687, 1993
12. Hültner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E, Dörmer P, Van Snick J: Mast cell growth enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin-9). Eur J Immunol 20:1413, 1990
13. Louahed J, Kermouni A, Van Snick J, Renauld J-C: IL-9 induces expression of granzymes and high affinity IgE receptor in murine T helper clones. J Immunol 154:5061, 1995
14. Demoulin J-B, Uyttenhove C, Van Roost E, de Lestré B, Donckers D, Van Snick J, Renauld J-C: A single tyrosine of the Interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol 16:4710, 1996
15. Palacios R, Steinmetz M: IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration and generate B lymphocytes in vivo. Cell 41:727, 1985
16. +T cells but is not a general T cell growth factor. Eur J Immunol 19:2167, 1989
17. Druez C, Coulie P, Uyttenhove C, Van Snick J: Functional and biochemical characterization of mouse P40/IL-9 receptors. J Immunol 145:2494, 1990
18. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K: Current Protocols in Molecular Biology, vol 1 and 2. New York, NY, Greene Publishing Association, 1993
19. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640, 1994
20. Schreiber E, Matthias P, Müller M, Schaffner W: Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
21. Mizushima S, Nagata S: pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322, 1990
22. Louahed J, Renauld J-C, Demoulin I-B, Baughman G, Bourgeois S, Sugamura K, Van Snick J: Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J Immunol 156:3704, 1996
23. Kimmelman A, Tolkacheva T, Lorenzi MV, Osada M, Chan AM-L: Identification and characterization of R-ras3: A novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene 15:2675, 1997
24. Matsumoto K, Asano T, Endo T: Novel small GTPase M-Ras participates in reorganization of actin cytoskelelon. Oncogene 15:2409, 1997
25. Glomset JA, Farnsworth CC: Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu Rev Cell Biol 10:181, 1994
26. Gelb MH: Protein prenylation, et cetera: Signal transduction in two dimensions. Science 275:1750, 1997
27. Godfraind C, Louahed J, Faulkner H, Vink A, Warnier G, Grencis R, Renauld J-C: Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol 160:3989, 1998
28. Feig L, Cooper GM: Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol 8:2472, 1988
29. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489, 1995
30. Terada K, Kaziro Y, Satoh T: Ras is not required for interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. J Biol Chem 270:27880, 1995
31. Demoulin JB, Maisin D, Renauld J-C: Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells. Eur Cytokine Netw 10:49, 1999
32. Suzuki J, Kaziro Y, Koide H: An activated mutant of R-Ras inhibits cell death caused by cytokine deprivation in BaF3 cells in the presence of IGF-I. Oncogene 15:1689, 1997
33. Kinoshita T, Shirouzu M, Kamiya A, Hashimoto K, Yokoyama S, Miyajima A: Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells. Oncogene 15:619, 1997